JP Morgan Chase
TTNP

JP Morgan Chase’s Titan Pharmaceuticals TTNP Stock Holding History

JP Morgan Chase’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$64 – 7895
2023
Q4 		$64 Hold
8
– – ﹤0.01% 7173
2023
Q3 		$73 Buy
8
+5
+167% +$54 ﹤0.01% 6949
2023
Q2 		$40 Hold
3
– – ﹤0.01% 6756
2023
Q1 		$0 Hold
3
– – ﹤0.01% 7232
2022
Q4 		$0 Buy
+3
New +$57 ﹤0.01% 7006
2021
Q4 		– Hold
0
– – – 6965
2021
Q3 		– Sell
-1
Closed -$44 – 6811
2021
Q2 		$0 Sell
1
-3
-75% -$150 ﹤0.01% 6619
2021
Q1 		$0 Buy
+4
New +$265 ﹤0.01% 6360
2020
Q1 		– Hold
0
– – – 5736
2019
Q4 		– Hold
0
– – – 5892
2019
Q3 		– Hold
0
– – – 5969
2019
Q2 		– Hold
0
– – – 6020
2019
Q1 		– Hold
0
– – – 6060
2018
Q4 		– Hold
0
– – – 5950
2018
Q3 		– Hold
0
– – – 5831
2018
Q2 		– Hold
0
– – – 5497
2018
Q1 		– Hold
0
– – – 5640
2017
Q4 		– Hold
0
– – – 5581
2017
Q3 		– Hold
0
– – – 5189
2017
Q2 		– Hold
0
– – – 5228
2017
Q1 		– Hold
0
– – – 5239
2016
Q4 		– Hold
0
– – – 5136
2016
Q3 		– Hold
0
– – – 4811
2016
Q2 		– Hold
0
– – – 4956

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

JP Morgan Chase's TTNP Position: Q1 2024 in Review

JP Morgan Chase sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 8 shares — an estimated $64 sold.

JP Morgan Chase first reported a position in TTNP in Q1 2021 and held it in 7 quarters. The position peaked at $73 in Q3 2023. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.

  • JP Morgan Chase reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 8 Titan Pharmaceuticals shares in Q1 2024, an estimated $64.
  • JP Morgan Chase first reported a position in Titan Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • JP Morgan Chase's Titan Pharmaceuticals position peaked at $73 in Q3 2023.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.